McPate MJ - Search Results

1

hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.

McPate MJ, Zhang H, Cordeiro JM, Dempsey CE, Witchel HJ, Hancox JC. McPate MJ, et al. Biochem Biophys Res Commun. 2009 Aug 14;386(1):111-7. doi: 10.1016/j.bbrc.2009.05.134. Epub 2009 Jun 6. Biochem Biophys Res Commun. 2009. PMID: 19501051 Free PMC article.

2

Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin.

Duncan RS, McPate MJ, Ridley JM, Gao Z, James AF, Leishman DJ, Leaney JL, Witchel HJ, Hancox JC. Duncan RS, et al. Among authors: mcpate mj. Biochem Pharmacol. 2007 Aug 1;74(3):425-37. doi: 10.1016/j.bcp.2007.04.024. Epub 2007 May 3. Biochem Pharmacol. 2007. PMID: 17560554 Free PMC article.

3

Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.

McPate MJ, Duncan RS, Hancox JC, Witchel HJ. McPate MJ, et al. Br J Pharmacol. 2008 Nov;155(6):957-66. doi: 10.1038/bjp.2008.325. Epub 2008 Aug 25. Br J Pharmacol. 2008. PMID: 18724381 Free PMC article.

4

Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.

McPate MJ, Zhang H, Adeniran I, Cordeiro JM, Witchel HJ, Hancox JC. McPate MJ, et al. J Physiol Pharmacol. 2009 Mar;60(1):23-41. J Physiol Pharmacol. 2009. PMID: 19439805 Free article.

5

Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.

El Harchi A, McPate MJ, Zhang YH, Zhang H, Hancox JC. El Harchi A, et al. Among authors: mcpate mj. J Physiol Pharmacol. 2010 Apr;61(2):123-31. J Physiol Pharmacol. 2010. PMID: 20436212 Free article.

6

Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform.

Du CY, El Harchi A, McPate MJ, Orchard CH, Hancox JC. Du CY, et al. Among authors: mcpate mj. Biochem Biophys Res Commun. 2011 Feb 11;405(2):222-7. doi: 10.1016/j.bbrc.2011.01.014. Epub 2011 Jan 8. Biochem Biophys Res Commun. 2011. PMID: 21219869

7

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C.

McPate MJ, Duncan RS, Milnes JT, Witchel HJ, Hancox JC. McPate MJ, et al. Biochem Biophys Res Commun. 2005 Aug 26;334(2):441-9. doi: 10.1016/j.bbrc.2005.06.112. Biochem Biophys Res Commun. 2005. PMID: 16011830

8

Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656.

Ridley JM, Milnes JT, Duncan RS, McPate MJ, James AF, Witchel HJ, Hancox JC. Ridley JM, et al. Among authors: mcpate mj. FEBS Lett. 2006 Apr 3;580(8):1999-2005. doi: 10.1016/j.febslet.2006.02.073. Epub 2006 Mar 7. FEBS Lett. 2006. PMID: 16542653 Free article.

9

Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.

McPate MJ, Duncan RS, Witchel HJ, Hancox JC. McPate MJ, et al. J Mol Cell Cardiol. 2006 Sep;41(3):563-6. doi: 10.1016/j.yjmcc.2006.05.021. Epub 2006 Jul 12. J Mol Cell Cardiol. 2006. PMID: 16842817

10

Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.

El Harchi A, McPate MJ, Zhang Yh, Zhang H, Hancox JC. El Harchi A, et al. Among authors: mcpate mj. J Mol Cell Cardiol. 2009 Nov;47(5):743-7. doi: 10.1016/j.yjmcc.2009.02.027. Epub 2009 Mar 10. J Mol Cell Cardiol. 2009. PMID: 19285083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters